BELINDA LONGMORE: Open Payments
NPI 1306481502 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,384 in 51 payments from 19 companies in 2025. Trend: 2023 $358 · 2024 $1,665 · 2025 $1,384
Food & beverage: $1,384
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $297 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $185 |
| Neurocrine BioSciences, Inc. | 4 | $182 |
| Bioventus LLC | 2 | $155 |
| Axsome Therapeutics, Inc. | 11 | $144 |
| Teva Pharmaceuticals USA, Inc. | 1 | $85 |
| Janssen Pharmaceuticals, Inc | 4 | $76 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $33 |
| HARMONY BIOSCIENCES LLC | 1 | $26 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, Auvelity, AUSTEDO XR, DUROLANE, EXOGEN ULTRASOUND BONE HEALING SYSTEM, SPRAVATO.
Industry payments across OH — which companies pay providers there.
